Vascularized composite allotransplantation at a crossroad.

Vascularized composite allotransplantation is a relatively young field that has shown significant growth in the past decade. The subspecialty offers opportunities that are not available with solid organ transplants. However, the field also faces significant hurdles in increasing clinical volumes. The development of innovative immune-reduction strategies will likely determine the pace and direction of growth in the field in the years to come.

[1]  R. Lechler,et al.  Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. , 2008, The Journal of clinical investigation.

[2]  V. Gorantla,et al.  Composite tissue allotransplantation in chimeric hosts: part I. prevention of graft-versus-host disease1 , 2003, Transplantation.

[3]  E. Engleman,et al.  Tolerance and chimerism after renal and hematopoietic-cell transplantation. , 2008, The New England journal of medicine.

[4]  S. Schneeberger,et al.  Composite tissue allotransplantation: hand transplantation and beyond. , 2010, The Journal of the American Academy of Orthopaedic Surgeons.

[5]  E. Rodriguez,et al.  Vascularized Bone Marrow‐Based Immunosuppression Inhibits Rejection of Vascularized Composite Allografts in Nonhuman Primates , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  B. Griffith,et al.  A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. , 2000, The Journal of thoracic and cardiovascular surgery.

[7]  W. Telford,et al.  Regulatory T Cells and Human Myeloid Dendritic Cells Promote Tolerance via Programmed Death Ligand-1 , 2010, PLoS biology.

[8]  S. Trigg.  The International Registry on Hand and Composite Tissue Transplantation , 2011 .

[9]  M. Lanzettà,et al.  Human hand allograft: report on first 6 months , 1999, The Lancet.

[10]  Wei-Chao Huang,et al.  Dissociation Between Peripheral Blood Chimerism and Tolerance to Hindlimb Composite Tissue Transplants: Preferential Localization of Chimerism in Donor Bone , 2009, Transplantation.

[11]  T. Strom,et al.  Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T‐cell function in transplantation , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[12]  P. Chilton,et al.  Production of Donor T Cells Is Critical for Induction of Donor-Specific Tolerance and Maintenance of Chimerism1 , 2004, The Journal of Immunology.

[13]  R. Foster,et al.  Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade , 2003, Transplantation.

[14]  S. Ildstad,et al.  Evidence That FoxP3+ Regulatory T Cells May Play a Role in Promoting Long-Term Acceptance of Composite Tissue Allotransplants , 2011, Transplantation.

[15]  Allen R. Chen,et al.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[16]  V. Gorantla,et al.  Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model , 2003, Transplantation.

[17]  V. Sharma,et al.  HLA-mismatched renal transplantation without maintenance immunosuppression. , 2008, The New England journal of medicine.

[18]  Jean Kanitakis,et al.  Composite Tissue Allograft Extends a Helping Hand to Transplant Immunologists , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  D. Mathes,et al.  A survey of north american hand surgeons on their current attitudes toward hand transplantation. , 2009, The Journal of hand surgery.

[20]  D. Sachs,et al.  Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts , 1984, Nature.

[21]  S. Nasir,et al.  New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[22]  M. Abecassis,et al.  Implementation of Vascularized Composite Allografts in the United States: Recommendations From the ASTS VCA Ad Hoc Committee and the Executive Committee , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  Frédéric Schuind,et al.  The International Registry on Hand and Composite Tissue Transplantation , 2010, Transplantation.

[24]  R. Lechler,et al.  The importance of the indirect pathway of allorecognition in clinical transplantation. , 2008, Current opinion in immunology.

[25]  T. Wekerle,et al.  Bone marrow transplantation as a strategy for tolerance induction in the clinic. , 2009, Frontiers in bioscience.